These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 16934692)
1. Comparison of the uptake of [123/125I]-2-iodo-D-tyrosine and [123/125I]-2-iodo-L-tyrosine in R1M rhabdomyosarcoma cells in vitro and in R1M tumor-bearing Wag/Rij rats in vivo. Bauwens M; Lahoutte T; Kersemans K; Gallez C; Bossuyt A; Mertens J Nucl Med Biol; 2006 Aug; 33(6):735-41. PubMed ID: 16934692 [TBL] [Abstract][Full Text] [Related]
2. In vivo characterization of 123/125I-2-iodo-L-phenylalanine in an R1M rhabdomyosarcoma athymic mouse model as a potential tumor tracer for SPECT. Kersemans V; Cornelissen B; Kersemans K; Bauwens M; Achten E; Dierckx RA; Mertens J; Slegers G J Nucl Med; 2005 Mar; 46(3):532-9. PubMed ID: 15750170 [TBL] [Abstract][Full Text] [Related]
3. Comparative biodistribution study of the new tumor tracer [123I]-2-iodo-L-phenylalanine with [123I]-2-iodo-L-tyrosine. Kersemans V; Cornelissen B; Kersemans K; Dierckx RA; De Spiegeleer B; Mertens J; Slegers G Nucl Med Biol; 2006 Jan; 33(1):111-7. PubMed ID: 16459266 [TBL] [Abstract][Full Text] [Related]
4. D- and L-[123I]-2-I-phenylalanine show a long tumour retention compared with D- and L-[123I]-2-I-tyrosine in R1M rhabdomyosarcoma tumour-bearing Wag/Rij rats. Bauwens M; Lahoutte T; Kersemans K; Caveliers V; Bossuyt A; Mertens J Contrast Media Mol Imaging; 2007 Jul; 2(4):172-7. PubMed ID: 17683118 [TBL] [Abstract][Full Text] [Related]
5. In vivo evaluation and dosimetry of 123I-2-iodo-D-phenylalanine, a new potential tumor-specific tracer for SPECT, in an R1M rhabdomyosarcoma athymic mouse model. Kersemans V; Cornelissen B; Bacher K; Kersemans K; Thierens H; Dierckx RA; De Spiegeleer B; Slegers G; Mertens J J Nucl Med; 2005 Dec; 46(12):2104-11. PubMed ID: 16330577 [TBL] [Abstract][Full Text] [Related]
6. 123/125I-labelled 2-iodo-L: -phenylalanine and 2-iodo-D: -phenylalanine: comparative uptake in various tumour types and biodistribution in mice. Kersemans V; Cornelissen B; Kersemans K; Bauwens M; Dierckx RA; De Spiegeleer B; Mertens J; Slegers G Eur J Nucl Med Mol Imaging; 2006 Aug; 33(8):919-27. PubMed ID: 16572305 [TBL] [Abstract][Full Text] [Related]
7. Synthesis, radiosynthesis, and in vitro characterization of [125I]-2- iodo-L-phenylalanine in a R1M rhabdomyosarcoma cell model as a new potential tumor tracer for SPECT. Mertens J; Kersemans V; Bauwens M; Joos C; Lahoutte T; Bossuyt A; Slegers G Nucl Med Biol; 2004 Aug; 31(6):739-46. PubMed ID: 15246364 [TBL] [Abstract][Full Text] [Related]
8. Investigation of transport mechanism and uptake kinetics of O-(2-[18F]fluoroethyl)-L-tyrosine in vitro and in vivo. Heiss P; Mayer S; Herz M; Wester HJ; Schwaiger M; Senekowitsch-Schmidtke R J Nucl Med; 1999 Aug; 40(8):1367-73. PubMed ID: 10450690 [TBL] [Abstract][Full Text] [Related]
9. Intra-individual comparison of the human biodistribution and dosimetry of the D and L isomers of 2-[123I]iodo-phenylalanine. Bauwens M; Keyaerts M; Lahoutte T; Kersemans K; Caveliers V; Bossuyt A; Mertens J Nucl Med Commun; 2007 Oct; 28(10):823-8. PubMed ID: 17728613 [TBL] [Abstract][Full Text] [Related]
10. Increased tumor uptake of 3-(123)I-Iodo-L-alpha-methyltyrosine after preloading with amino acids: an in vivo animal imaging study. Lahoutte T; Caveliers V; Franken PR; Bossuyt A; Mertens J; Everaert H J Nucl Med; 2002 Sep; 43(9):1201-6. PubMed ID: 12215559 [TBL] [Abstract][Full Text] [Related]
11. Transport of D-[1-14C]-amino acids into Chinese hamster ovary (CHO-K1) cells: implications for use of labeled d-amino acids as molecular imaging agents. Shikano N; Nakajima S; Kotani T; Ogura M; Sagara J; Iwamura Y; Yoshimoto M; Kubota N; Ishikawa N; Kawai K Nucl Med Biol; 2007 Aug; 34(6):659-65. PubMed ID: 17707806 [TBL] [Abstract][Full Text] [Related]
12. L-type amino acid transporters LAT1 and LAT4 in cancer: uptake of 3-O-methyl-6-18F-fluoro-L-dopa in human adenocarcinoma and squamous cell carcinoma in vitro and in vivo. Haase C; Bergmann R; Fuechtner F; Hoepping A; Pietzsch J J Nucl Med; 2007 Dec; 48(12):2063-71. PubMed ID: 18056335 [TBL] [Abstract][Full Text] [Related]
13. Influence of sedation and data acquisition method on tracer uptake in animal models: [123I]-2-iodo-L-phenylalanine in pentobarbital-sedated tumor-bearing athymic mice. Kersemans V; De Spiegeleer B; Mertens J; Slegers G Nucl Med Biol; 2006 Jan; 33(1):119-23. PubMed ID: 16459267 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the biodistribution and tumor targeting of two 99mTc-labeled anti-EGFR nanobodies in mice, using pinhole SPECT/micro-CT. Gainkam LO; Huang L; Caveliers V; Keyaerts M; Hernot S; Vaneycken I; Vanhove C; Revets H; De Baetselier P; Lahoutte T J Nucl Med; 2008 May; 49(5):788-95. PubMed ID: 18413403 [TBL] [Abstract][Full Text] [Related]
15. The use of [123I]-2-iodo-L-phenylalanine as an early radiotherapy evaluation tool: in vitro R1M rabdomyosarcoma cell and in vivo mouse experiments. Kersemans V; Vergote V; de Gelder V; Madani I; Thierens H; De Neve W; Mertens J; Slegers G; Burvenich C; Peremans K; De Spiegeleer B Cancer Biother Radiopharm; 2008 Apr; 23(2):192-201. PubMed ID: 18454688 [TBL] [Abstract][Full Text] [Related]
17. Assessment of insulin sensitivity in vivo in control and diabetic mice with a radioactive tracer of glucose transport: [125I]-6-deoxy-6-iodo-D-glucose. Perret P; Ghezzi C; Mathieu JP; Morin C; Fagret D Diabetes Metab Res Rev; 2003; 19(4):306-12. PubMed ID: 12879408 [TBL] [Abstract][Full Text] [Related]